May 9, 2013
SITC Announces Dr. Carl June as
2013 Richard V. Smalley, MD Memorial Award Recipient
SITC's most prestigious award will be presented to Dr. June at the Society's Annual Meeting
 |
|
Dr. Carl June
|
In recognition of his pioneering research in the immunologic treatment of cancer, the Society for Immunotherapy of Cancer (SITC) will honor Carl June, MD, the Richard W. Vague Professor of Immunotherapy in the Perelman School of Medicine and the Director of translational research at the Abramson Cancer Center at the University of Pennsylvania, with the 2013 Richard V. Smalley, MD Memorial Award.
SITC's most distinguished award will be presented to Dr. June at the Society’s Annual Meeting awards ceremony on Saturday, November 9, 2013 at the Gaylord National Hotel & Convention Center in National Harbor, MD. Prior to this, Dr. June will give a keynote lectureship as part of the Annual Meeting schedule.
“SITC is proud to present Dr. Carl June with our most prestigious award, the Richard V. Smalley, MD Memorial Award,” said Society President Francesco M. Marincola, MD. “Dr. June has been a tireless proponent of the immunologic treatment of cancer, developing revolutionary new technologies and helping to bring them into clinical practice. His research using genetically engineered versions of patients’ own T cells to attack tumors in patients with chronic lymphocytic leukemia, has opened up new horizons for the immunologic treatment of cancer.”
Established in 2005, this award is presented in memory of former Society President, Richard V. Smalley, MD, to honor a luminary in the field that has significantly contributed to the advancement of cancer immunotherapy research.
For more information on Dr. June, the Richard V. Smalley, MD Memorial Award and additional award opportunities for SITC 2013, visit: www.sitcancer.org/2013/annual-meeting/awards.
.jpg)
Get Ready for SITC 2013!
Registration and Housing Opens May 15 | Abstract Submission Opens May 29
Join over 800 domestic and international basic, clinical, and translational scientists from academia, government, and the biotech/pharmaceutical industry at SITC 2013, the premier destination for scientific exchange, education, and networking in the cancer immunotherapy community.
SITC 2013 Highlights:
- 28th Annual Meeting
- Workshop on Personalized Cancer Immunotherapy
- Primer on Tumor Immunology and Cancer ImmunotherapyTM
- Hot Topic Symposium
- Specific Programming for Young Investigators
- Opportunities for Presidential and Abstract Travel Awards
Stay tuned for more SITC 2013 information, important dates and deadlines coming soon!
.jpg)
Submit your research to the Journal for ImmunoTherapy of Cancer, the official journal of SITC! The Society is pleased to offer SITC members waived article processing charges for manuscripts accepted through 2013. For more information, visit: www.sitcancer.org/journal.
Now Accepting Submissions in:
|
 |
